Open Call for Research Proposals for BioCanRx
BioCanRx, Canada’s Immunotherapy Network, is launching its first Open Call for Research Proposals, made possible by funding from the Strategic Science Fund. By funding the selected proposals, BioCanRx will increase support for multi-disciplinary cancer immunotherapy and biotherapeutic approaches. More information is available here: https://biocanrx.com/research/research-program/open-call-2024
New CCRA Advisory Board Chair and Elected Representative
Effective January 1, 2026, CCRA welcomes new CCRA Advisory Board chair, Dr. James (Jim) Woodgett. Jim is the President and Scientific Director of the Terry Fox Research Institute (TFRI), a Senior Scientist at the Lunenfeld-Tanenbaum Research Institute at Sinai... Read More »
Effective January 1, 2026, CCRA welcomes new CCRA Advisory Board chair, Dr. James (Jim) Woodgett. Jim is the President and Scientific Director of the Terry Fox Research Institute (TFRI), a Senior Scientist at the Lunenfeld-Tanenbaum Research Institute at Sinai... Read More »
Are you a cancer patient, survivor, or caregiver who is interested in learning more about cancer research?
CCRA’s Patient Involvement in Cancer Research Program (known as PIP) will be offered virtually in the fall of 2021. This program is designed for cancer patients, survivors, and caregivers with an interest in learning more about cancer research and how they can contribute to the re... Read More »
CCRA’s Patient Involvement in Cancer Research Program (known as PIP) will be offered virtually in the fall of 2021. This program is designed for cancer patients, survivors, and caregivers with an interest in learning more about cancer research and how they can contribute to the re... Read More »